9-ethyl-6,6-dimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile monohydrochloride salt | 1256589-70-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 9-ethyl-6,6-dimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile monohydrochloride salt
• 英文别名: 9-ethyl-6,6-dimethyl-8-[4-(oxetan-3-yl)piperazin-1-yl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile;hydrochloride
• CAS: 1256589-70-4
• 化学式: C₂₈H₃₀N₄O₂*ClH
• 分子量: 491.033
• InChiKey: XJZRMRCCOQULJJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.41
• 重原子数：
  35
• 可旋转键数：
  3
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  72.4
• 氢给体数：
  2
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  9-ethyl-6,6-dimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile 在 盐酸 作用下， 以 水 、 二甲基亚砜 为溶剂， 生成 9-ethyl-6,6-dimethyl-8-(4-oxetan-3-yl-piperazin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile monohydrochloride salt
  参考文献：
  名称：

  COMPOSITION COMPRISING TETRACYCLIC COMPOUND

  摘要：

  由公式（I）代表的物质，药用可接受的载体和溶解助剂组成的组合物，可用于改善具有ALK抑制活性的水溶性差或水不溶的四环化合物的溶解度、口服吸收性和/或血液吸收性，这些化合物可用作癌症、抑郁症和认知功能障碍的预防和/或治疗药物。

  公开号：

  US20130143877A1

文献信息

• COMPOSITION CONTAINING TETRACYCLIC COMPOUND
  申请人：Chugai Seiyaku Kabushiki Kaisha

  公开号：EP2606886A1

  公开（公告）日：2013-06-26

  A composition which comprises substance represented by Formula (I), [Meanings of the symbols that are included in the formula are given in the specification as definitions] a pharmaceutically acceptable carrier, and a dissolution aid.is useful for improving solubility, oral absorbability and/or absorbability in blood of a poorly water-soluble or water insoluble tetracyclic compounds having an ALK inhibitory activity that are useful as a prophylactic and/or therapeutic agent for cancer, depression, and cognitive function disorder.

  一种由式 (I) 所代表的物质组成的组合物、 式（I）代表的物质，[式（I）中包含的符号的含义在说明书中作为定义给出]。 用于改善具有 ALK 抑制活性的水溶性差或不溶于水的四环化合物的溶解度、口服可吸收性和/或血液可吸收性，该化合物可用作癌症、抑郁症和认知功能障碍的预防剂和/或治疗剂。
• Composition comprising tetracyclic compound
  申请人：CHUGAI SEIYAKU KABUSHIKI KAISHA

  公开号：US10646468B2

  公开（公告）日：2020-05-12

  A composition which comprises substance represented by Formula (I), [Meanings of the symbols that are included in the formula are given in the specification as definitions] a pharmaceutically acceptable carrier, and a dissolution aid.is useful for improving solubility, oral absorbability and/or absorbability in blood of a poorly water-soluble or water insoluble tetracyclic compounds having an ALK inhibitory activity that are useful as a prophylactic and/or therapeutic agent for cancer, depression, and cognitive function disorder.

  一种由式 (I) 所代表的物质组成的组合物、 [式中所含符号的含义在本说明书中作为定义给出] 2. 可用于改善具有 ALK 抑制活性的水溶性差或不溶于水的四环化合物的溶解度、口服可吸收性和/或血液可吸收性，该化合物可用作癌症、抑郁症和认知功能障碍的预防和/或治疗药物。
• US9365514B2
  申请人：——

  公开号：US9365514B2

  公开（公告）日：2016-06-14
• COMPOSITION COMPRISING TETRACYCLIC COMPOUND
  申请人：Furumoto Kentaro

  公开号：US20130143877A1

  公开（公告）日：2013-06-06

  A composition which comprises substance represented by Formula (I), [Meanings of the symbols that are included in the formula are given in the specification as definitions] a pharmaceutically acceptable carrier, and a dissolution aid. is useful for improving solubility, oral absorbability and/or absorbability in blood of a poorly water-soluble or water insoluble tetracyclic compounds having an ALK inhibitory activity that are useful as a prophylactic and/or therapeutic agent for cancer, depression, and cognitive function disorder.

  由公式（I）代表的物质，药用可接受的载体和溶解助剂组成的组合物，可用于改善具有ALK抑制活性的水溶性差或水不溶的四环化合物的溶解度、口服吸收性和/或血液吸收性，这些化合物可用作癌症、抑郁症和认知功能障碍的预防和/或治疗药物。